2-[8-(2,4-Dichloro-phenyl)-2-oxo-octyl]-2-hydroxy-succinic acid

ID: ALA121948

Chembl Id: CHEMBL121948

PubChem CID: 10431376

Max Phase: Preclinical

Molecular Formula: C18H22Cl2O6

Molecular Weight: 405.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CC(O)(CC(=O)CCCCCCc1ccc(Cl)cc1Cl)C(=O)O

Standard InChI:  InChI=1S/C18H22Cl2O6/c19-13-8-7-12(15(20)9-13)5-3-1-2-4-6-14(21)10-18(26,17(24)25)11-16(22)23/h7-9,26H,1-6,10-11H2,(H,22,23)(H,24,25)

Standard InChI Key:  YYQRLLLEXVHQGE-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acly ATP-citrate synthase (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.27Molecular Weight (Monoisotopic): 404.0793AlogP: 3.74#Rotatable Bonds: 12
Polar Surface Area: 111.90Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.60CX Basic pKa: CX LogP: 4.27CX LogD: -1.05
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.46Np Likeness Score: 0.33

References

1. Gribble AD, Dolle RE, Shaw A, McNair D, Novelli R, Novelli CE, Slingsby BP, Shah VP, Tew D, Saxty BA, Allen M, Groot PH, Pearce N, Yates J..  (1996)  ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.,  39  (18): [PMID:8784456] [10.1021/jm960167w]
2. Granchi C..  (2018)  ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.,  157  [PMID:30195238] [10.1016/j.ejmech.2018.09.001]

Source